HRU: all alloHSCT patients
| . | Pre-alloHSCT . | Post-alloHSCT (years 1,2)* . | |
|---|---|---|---|
| Mean number per patient . | Year −1 . | Year 1 . | Year 2 . |
| Mean ± SD . | n = 2162 . | n = 2162 . | n = 1305 . |
| Patients with 1+ hospital admission, n (%) | 1614 (75) | 1895 (88) | 398 (30) |
| Number of inpatient admissions, per patient, mean ± SD | 2.9 ± 2.9 | 2.7 ± 3.2 | 0.8 ± 2.0 |
| Length of stay per admission (days), mean ± SD | 45.4 ± 64.6 | 50.4 ± 238.2 | 28.6 ± 55.8 |
| Annual number of outpatient visits per patient, mean ± SD | |||
| Physician office visit | 22.4 ± 19.9 | 21.5 ± 21.0 | 16.4 ± 16.8 |
| Outpatient hospital visit | 30.5 ± 24.2 | 45.2 ± 33.0 | 19.4 ± 22.9 |
| ED visit | 1.1 ± 2.7 | 0.9 ± 2.3 | 0.6 ± 1.2 |
| Number of pulmonary function test dates of any kind† | 2.3 ± 1.8 | 1.8 ± 2.7 | 1.7 ± 3.0 |
| Number of days with 1+ treatments of any kind | 0.9 ± 1.8 | 1.7 ± 5.7 | 2.1 ± 7.5 |
| Annual number of prescription fills per patient, mean ± SD | |||
| Chemotherapy | 5.8 ± 9.3 | 2.2 ± 5.6 | 1.4 ± 4.3 |
| Immunosuppressive agents | 0.4 ± 2.3 | 6.9 ± 8.9 | 3.4 ± 6.7 |
| Antifungals | 0.3 ± 2.3 | 1.7 ± 7.5 | 0.6 ± 4.7 |
| Antibiotics | 3.1 ± 3.2 | 4.0 ± 5.3 | 3.7 ± 4.9 |
| Antivirals | 1.6 ± 2.4 | 7.6 ± 7.4 | 4.5 ± 4.9 |
| . | Pre-alloHSCT . | Post-alloHSCT (years 1,2)* . | |
|---|---|---|---|
| Mean number per patient . | Year −1 . | Year 1 . | Year 2 . |
| Mean ± SD . | n = 2162 . | n = 2162 . | n = 1305 . |
| Patients with 1+ hospital admission, n (%) | 1614 (75) | 1895 (88) | 398 (30) |
| Number of inpatient admissions, per patient, mean ± SD | 2.9 ± 2.9 | 2.7 ± 3.2 | 0.8 ± 2.0 |
| Length of stay per admission (days), mean ± SD | 45.4 ± 64.6 | 50.4 ± 238.2 | 28.6 ± 55.8 |
| Annual number of outpatient visits per patient, mean ± SD | |||
| Physician office visit | 22.4 ± 19.9 | 21.5 ± 21.0 | 16.4 ± 16.8 |
| Outpatient hospital visit | 30.5 ± 24.2 | 45.2 ± 33.0 | 19.4 ± 22.9 |
| ED visit | 1.1 ± 2.7 | 0.9 ± 2.3 | 0.6 ± 1.2 |
| Number of pulmonary function test dates of any kind† | 2.3 ± 1.8 | 1.8 ± 2.7 | 1.7 ± 3.0 |
| Number of days with 1+ treatments of any kind | 0.9 ± 1.8 | 1.7 ± 5.7 | 2.1 ± 7.5 |
| Annual number of prescription fills per patient, mean ± SD | |||
| Chemotherapy | 5.8 ± 9.3 | 2.2 ± 5.6 | 1.4 ± 4.3 |
| Immunosuppressive agents | 0.4 ± 2.3 | 6.9 ± 8.9 | 3.4 ± 6.7 |
| Antifungals | 0.3 ± 2.3 | 1.7 ± 7.5 | 0.6 ± 4.7 |
| Antibiotics | 3.1 ± 3.2 | 4.0 ± 5.3 | 3.7 ± 4.9 |
| Antivirals | 1.6 ± 2.4 | 7.6 ± 7.4 | 4.5 ± 4.9 |
This table shows the HRU for all patients that received an alloHSCT transplant in the follow-up years 1 and 2 compared with the period before transplant.
Years 3 through 5 in supplemental Materials.
Pulmonary function test includes spirometry, lung function volume, lung diffusion capacity, and plethysmography.